关键词
ActemraAmgevitaAvsolaBrenzysCimziaEnbrelErelziHadlimaHulioHumiraHyrimozIdacioInflectraKevzaraOlumiantOrenciaRemicadeRemsimaRenflexisRiabniRinvoqRituxanRiximyoRuxienceSimponiTNF inhibitorsTruximaXeljanzabataceptadalimumabadverse effectsbaricitinibcertolizumabdosageetanerceptgolimumabinfliximablactationpregnancyrheumatoid arthritisrituximabsafetysarilumabtocilizumabtofacitinibupadacitinib
主题词
抗风湿药(Antirheumatic Agents);关节炎, 类风湿(Arthritis, Rheumatoid);生物因子(Biological Factors);决策支持技术(Decision Support Techniques);药物疗法, 联合(Drug Therapy, Combination);人类(Humans);病人遴选(Patient Selection);试验预期值(Predictive Value of Tests);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome)
PMID
35085212
发布时间
2022-02-07
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文